Organism: Homo sapiens
Gene: 1553322_s_at
Selected probe(set): 224955_at
Platform: Affymetrix Human Genome U133 Plus 2.0 Array

Expression of 1553322_s_at (224955_at) across 6672 perturbations tested by GENEVESTIGATOR:

Relative Expression (log2-ratio):-3.9233541
Number of Samples:2 / 2

Experimental	zalypsis study 2
	OPM1 multiple myeloma cells treated in vitro with zalypsis (5 nM), a novel marine-derived compound with potent antimyeloma activity. Cells were harvested at the beginning of induction of cell death (15-20% cell death as assessed by Annexin V-FITC staining). ATC code:---
Control	untreated OPM1 cell sample
	OPM1 multiple myeloma cells untreated.

Relative Expression (log2-ratio):-3.8457022
Number of Samples:2 / 2

Experimental	zalypsis study 1
	MM1S multiple myeloma cells treated in vitro with zalypsis (5 nM), a novel marine-derived compound with potent antimyeloma activity. Cells were harvested at the beginning of induction of cell death (15-20% cell death as assessed by Annexin V-FITC staining). ATC code:---
Control	untreated MM1S cell sample
	MM1S multiple myeloma cells untreated.

Relative Expression (log2-ratio):2.9963818
Number of Samples:10 / 10

Experimental	breast cancer study 24
	Freshly purified CD4+ tumor-infiltrating T cells derived from female primary invasive breast ductal carcinoma. For individual patient characteristics see detailed sample information. The initial tissue dissociation was performed mechanically, without enzymatic digestion.
Control	breast cancer study 22
	Freshly purified CD4+ T cells from peripheral blood of female donors with primary invasive breast ductal carcinoma. For individual patient characteristics see detailed sample information.

Relative Expression (log2-ratio):-2.8963213
Number of Samples:3 / 3

Experimental	oncolytic herpes simplex virus study 2
	Human malignant peripheral nerve sheath tumor (S462) cells infected with G207, an ICP34.5-deleted oncolytic herpes simplex virus (oHSV) for 6 hours.
Control	mock infected peripheral nerve sheath tumor (S462) cell sample
	Human malignant peripheral nerve sheath tumor (S462) cells mock infected for 6 hours.

Relative Expression (log2-ratio):-2.8026981
Number of Samples:2 / 2

Experimental	bone cancer study 1 (PDX; osteosarcoma, NOS; primary)
	Patient-derived xenograft (PDX) samples generated in female athymic nude mice from patients with primary osteosarcoma, NOS of the bone (subcutaneously implanted).
Control	bone cancer study 1 (PDX; myxoid chondrosarcoma; primary)
	Patient-derived xenograft (PDX) samples generated in female athymic nude mice from patients with primary myxoid chondrosarcoma of the bone (subcutaneously implanted).

Relative Expression (log2-ratio):2.769229
Number of Samples:2 / 17

Experimental	Roberts syndrome study 1
	Lymphoblastoid cell line samples from probands with Roberts syndrome (RBS).
Control	Cornelia de Lange syndrome study 1
	Lymphoblastoid cell line samples from severely affected Cornelia de Lange syndrome (CdLS) probands with NIPBL isoform B protein-truncating mutations.

Relative Expression (log2-ratio):2.768839
Number of Samples:8 / 8

Experimental	PMA; ionomycine study 2
	CD4+ memory T cells derived from peripheral blood of healthy subjects were stimulated for 3 hours with phorbol 12-myristate 13-acetate (PMA, 10 ng/ml) and ionomycin (1 µg/ml). ATC code:---
Control	unstimulated CD4 memory T-cell sample
	Unstimulated CD4+ memory T cells derived from peripheral blood of healthy subjects.

Relative Expression (log2-ratio):-2.6784496
Number of Samples:4 / 4

Experimental	stem cell differentiation study 50 (MYB shRNA; ASC; proerythroblast)
	Proerythroblast differentiated from MYB shRNA transduced hematopoietic stem/progenitor cells (CD34+). CD34+ hematopoietic stem/progenitor cells (HSC) were transduced with lentivirus expressing shRNA targeting MYB gene with following differentiation to the erythroid lineage. HSCs were obtained from magnetically sorted G-CSF mobilized peripheral blood mononuclear cells of healthy donors. Cells were expanded in StemSpan SFEM medium supplied with Flt-3 ligand (100 ng/ml), SCF (100 ng/ml), IL-3 (20 ng/ml), IL-6 (20 ng/ml) and penicillin/streptomycin. Cells were harvested for total RNA extraction at the proerythroblast stage of differentiation.
Control	stem cell differentiation study 50 (mock shRNA; ASC; proerythroblast)
	Proerythroblast differentiated from control shRNA transduced hematopoietic stem/progenitor cells (CD34+). CD34+ hematopoietic stem/progenitor cells (HSC) were transduced with lentivirus expressing control shRNA with following differentiation to the erythroid lineage. HSCs were obtained from magnetically sorted G-CSF mobilized peripheral blood mononuclear cells of healthy donors. Cells were expanded in StemSpan SFEM medium supplied with Flt-3 ligand (100 ng/ml), SCF (100 ng/ml), IL-3 (20 ng/ml), IL-6 (20 ng/ml) and penicillin/streptomycin. Cells were harvested for total RNA extraction at the proerythroblast stage of differentiation.

Relative Expression (log2-ratio):-2.5822868
Number of Samples:7 / 2

Experimental	breast cancer study 42 (metastase; lymph node)
	Metastatic tumor tissue obtained from the lymph node of patients with primary breast adenocarcinoma.
Control	breast cancer study 42 (metastase; chest wall)
	Metastatic tumor tissue obtained from the chest wall of patients with primary breast adenocarcinoma.

Relative Expression (log2-ratio):2.5594969
Number of Samples:2 / 18

Experimental	Roberts syndrome study 1
	Lymphoblastoid cell line samples from probands with Roberts syndrome (RBS).
Control	normal lymphoblastoid cell line sample
	Lymphoblastoid cell line samples from healthy subjects.